| RS2146022798 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146022877 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146023425 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146023608 |
MCOLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146023956 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146024231 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146024554 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146024743 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2146025414 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146025416 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2146025908 |
GREB1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Hearing loss, autosomal dominant 80 |
| RS2146026152 |
MCOLN1
|
Health Risk |
Likely pathogenic |
— |
| RS2146026596 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2146026614 |
SMARCB1
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome, SMARCB1-related disorder |
| RS2146028500 |
LTBP4
|
Health Risk |
Likely pathogenic |
LTBP4-related disorder, LTBP4-related disorder |
| RS2146029786 |
LTBP4
|
Health Risk |
Pathogenic/Likely pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS2146029958 |
DNMT3B
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 4, digenic |
| RS2146035624 |
ABHD12
|
Health Risk |
Pathogenic |
PHARC syndrome, PHARC syndrome |
| RS2146036001 |
BMP7
|
Health Risk |
Pathogenic |
Ventricular septal defect 1, Ventricular septal defect 1 |
| RS2146037598 |
LAMA5
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS2146038092 |
TMPRSS6
|
Health Risk |
Likely pathogenic |
Abnormality of metabolism/homeostasis, Abnormality of metabolism/homeostasis |
| RS2146042583 |
SMARCB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 15 |
| RS2146042724 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 1, Neoplasm |
| RS2146042856 |
SMARCB1
|
Health Risk |
Pathogenic |
SMARCB1-related schwannomatosis, SMARCB1-related schwannomatosis |
| RS2146045204 |
SMARCB1
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 1, Atypical teratoid rhabdoid tumor |
| RS2146047336 |
SYNJ1
|
Health Risk |
Pathogenic |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS2146050043 |
PNPLA6
|
Health Risk |
Pathogenic |
— |
| RS2146051234 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2146057065 |
KDM4B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 65 |
| RS2146057214 |
TMPRSS6
|
Health Risk |
Likely pathogenic |
Iron-refractory iron deficiency anemia, Iron-refractory iron deficiency anemia |
| RS2146057228 |
CFAP410
|
Health Risk |
Pathogenic |
Axial spondylometaphyseal dysplasia, Axial spondylometaphyseal dysplasia |
| RS2146057730 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2146058204 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2146058319 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2146058345 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146059828 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146059921 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146060162 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146060468 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146060616 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2146060644 |
KDM4B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2146061160 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146061284 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146061616 |
MC3R
|
Health Risk |
Conflicting classifications of pathogenicity |
MC3R-related disorder, OBESITY (BMIQ9) |
| RS2146061709 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146062270 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2146066005 |
RIPK4
|
Health Risk |
Likely pathogenic |
— |
| RS2146067261 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2146067632 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146068388 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146069782 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2146070088 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146070522 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146070648 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146071079 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146071112 |
ADAMTS10
|
Health Risk |
Pathogenic |
— |
| RS2146071181 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2146073581 |
COL18A1
|
Health Risk |
Likely pathogenic |
— |
| RS2146074371 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146074437 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146074788 |
KDM4B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 65 |
| RS2146074811 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146075448 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146075609 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146076572 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146076947 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS2146079806 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism, Pseudohypoparathyroidism |
| RS2146081689 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2146082310 |
DNMT3B
|
Health Risk |
Pathogenic |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS2146082887 |
ADAMTS10
|
Health Risk |
Pathogenic |
— |
| RS2146083122 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2146083140 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2146083176 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2146086468 |
PNPLA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia |
| RS2146088508 |
COL18A1
|
Health Risk |
Likely pathogenic |
— |
| RS2146090036 |
PNPLA6
|
Health Risk |
Pathogenic |
Laurence-Moon syndrome, Laurence-Moon syndrome |
| RS2146091582 |
PNPLA6
|
Health Risk |
Likely pathogenic |
Ataxia-hypogonadism-choroidal dystrophy syndrome, Ataxia-hypogonadism-choroidal dystrophy syndrome |
| RS2146092980 |
RTTN
|
Health Risk |
Pathogenic |
— |
| RS2146093747 |
ADAMTS10
|
Health Risk |
Pathogenic |
— |
| RS2146094265 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146095454 |
CRYBB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cataract 3 multiple types, Cataract 3 multiple types |
| RS2146098171 |
DNMT3B
|
Health Risk |
Likely pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, Immunodeficiency-centromeric instability-facial anomalies syndrome 1 |
| RS2146099465 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2146102535 |
ADAMTS10
|
Health Risk |
Pathogenic |
— |
| RS2146105309 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2146106285 |
ACO2
|
Health Risk |
Likely pathogenic |
— |
| RS2146107905 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2146108245 |
PNPLA6
|
Health Risk |
Pathogenic |
Rod-cone dystrophy, Rod-cone dystrophy |
| RS2146109671 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2146110600 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2146116814 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2146117027 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2146119643 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2146119824 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2146120226 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146120264 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146120283 |
TXNRD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS2146121253 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2146123001 |
PNPLA6
|
Health Risk |
Pathogenic |
Hypogonadism with anosmia, Hypogonadism with anosmia |
| RS2146124353 |
ACO2
|
Health Risk |
Likely pathogenic |
— |